Improving diabetes management for low-income Chinese immigrants
IDEAL: Implementing an Effective Diabetes intervEntion Among Low-income Immigrants
NA · NYU Langone Health · NCT06319703
This study is testing if a video program and support from community health workers can help low-income Chinese immigrants with Type 2 diabetes manage their condition better than just their usual care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 270 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | NYU Langone Health (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06319703 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the effectiveness of a video-based Diabetes Self-Management Education and Support (DSMES) program combined with community health worker support for Chinese immigrants with Type 2 diabetes in New York City. Participants will be randomly assigned to either receive weekly DSMES videos for 24 weeks or continue with their usual care. The community health worker will help identify and address social determinants of health that may hinder diabetes care. The study will compare the outcomes of the intervention group with a wait-list control group to assess improvements in glycemic control.
Who should consider this trial
Good fit: Ideal candidates are Chinese immigrants aged 18-70 with a diagnosis of Type 2 diabetes and an HbA1c level of 8% or higher.
Not a fit: Patients who are unable to provide informed consent or participate meaningfully in the intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve diabetes management and health outcomes for low-income Chinese immigrants.
How similar studies have performed: Previous studies have shown success with similar mobile health interventions for diabetes management, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants must: 1. self-identify as a Chinese immigrant; 2. be between 18-70 years old, 3. have a diagnosis of T2D in the medical record; 4. have had an appointment with a physician for routine T2D care within the past 12 months; 5. have a most recent HbA1c \> or = 8%; 6. be willing to receive brief videos regarding T2D management, and 7. possess a smartphone or, if they do not have one, be willing and able to use a study smartphone. Exclusion Criteria: 1. unable or unwilling to provide informed consent; 2. unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment); 3. unwilling to accept randomization assignment; 4. is pregnant, plans to become pregnant in the next 6 months, or becomes pregnant during the study, or 5. is breastfeeding (e.g., they may have potential dietary restrictions).
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Lu Hu, PhD — NYU School of Medicine
- Study coordinator: Lu Hu, PhD
- Email: Lu.hu@nyulangone.org
- Phone: 646-501-3438
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes, Mobile Health, mHealth